ARS Pharmaceuticals Outlines Strategic Priorities, including a Focused Commercial Strategy, and Reports Second Quarter 2026 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/21/2026

1. SPY
2. WBD
3. NVDA
4. PSKY
5. TSLA
6. USO
7. AMD
8. AMC
9. META
10. NUAI

Go back to ARS Pharmaceuticals Outlines Strategic Priorities, including a Focused Commercial Strategy, and Reports Second Quarter 2026 Financial Results
(NASDAQ: SPRY) Delayed: 4.37 +0.26 (6.33%)
Previous Close $4.11    52 Week High $ 
Open $4.16    52 Week Low $ 
Day High $4.39    P/E N/A 
Day Low $4.07    EPS $ 
Volume 786,010